Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VG081821AC in Early to Mid-Stage Parkinson's Disease
NCT07725562Phase 3Recruiting
- Sponsor
- Zhejiang Vimgreen Pharmaceuticals
- Start
- Jul 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 3 trial of VG081821AC in Parkinson's disease (PD), sponsored by Zhejiang Vimgreen Pharmaceuticals. Started Jul 2026; status: recruiting.
02
Drugs
VG081821AC
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07725562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07725562.